Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
29.00
+0.03 (0.10%)
Aug 14, 2025, 1:53 PM - Market open
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$86.64
Upside
+198.76%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $136 → $128 | Strong Buy | Maintains | $136 → $128 | +341.38% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $112 → $105 | Buy | Maintains | $112 → $105 | +262.07% | Aug 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +175.86% | Jul 28, 2025 |
| Wedbush | Wedbush | Hold Maintains $35 → $34 | Hold | Maintains | $35 → $34 | +17.24% | Jul 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +89.66% | Jul 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $88 → $65 | Buy | Maintains | $88 → $65 | +124.14% | Jul 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $64 | Strong Buy | Reiterates | $64 | +120.69% | Jun 20, 2025 |
| William Blair | William Blair | Buy Initiates $65 | Buy | Initiates | $65 | +124.14% | May 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $64 → $65 | Buy | Maintains | $64 → $65 | +124.14% | May 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $104 → $117 | Buy | Maintains | $104 → $117 | +303.45% | Mar 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $115 | Buy | Maintains | $140 → $115 | +296.55% | Mar 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +306.90% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +227.59% | Feb 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 → $136 | Strong Buy | Maintains | $121 → $136 | +368.97% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +227.59% | Feb 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +306.90% | Jan 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.